(3S,4R)-3-ethyl-4-{1,5,7,10-tetraazatricyclo[7.3.0.0²,?]dodeca-2(6),3,7,9,11-pentaen-12-yl}-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide;
Upadacitinib-d4 (Major) is a fully characterized chemical compound used as a reference standard of API Upadacitinib. The standard offered is compliant with regulatory guidelines. Upadacitinib-d4 (Major) is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
